Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Vertiv Holdings Co (VRT) Price & Performance

Roivant Sciences Ltd. Common SharesTrade
Vertiv Holdings CoTrade

Price performance (Past 24H)

Key statistics

Roivant Sciences Ltd. Common Shares vs Vertiv Holdings Co — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while Vertiv Holdings Co trades at $246.96 (market cap $94.90B). The key difference: Vertiv Holdings Co is far larger — about 3.8× Roivant Sciences Ltd. Common Shares's market cap, and Vertiv Holdings Co pays a 0.1% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Vertiv Holdings Co for 39 Days on average.

ROIVVRT
Market Cap
$25.09B$94.90B
Volume
5,738,5715,469,277
Sector
HealthIndustrials
52-Week High
$41.81$376.23
52-Week Low
$16.04$149.83
Typical Hold Time
0 Days39 Days
Enterprise Value
$21.36B$95.12B
Dividend Yield
—0.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Vertiv Holdings Co

Vertiv (VRT) trades at $246.49, down 2.63% amid bearish technical signals but maintains strong fundamental momentum with consistent earnings beats and robust AI-driven data center demand. The stock shows elevated valuation multiples (P/E 55.77, P/S 8.42) against impressive profitability (ROE 43.94%, net margin 15.09%), while analyst consensus remains overwhelmingly bullish with a $364.94 price target. Recent news highlights Vertiv's strategic positioning in AI infrastructure cooling solutions.

Outlook remains positive given Vertiv's exposure to the $7.6 trillion AI spending boom (Goldman Sachs, Sep 2026), though risks include potential securities law investigations and competitive pressures. The stock offers growth exposure to data center electrification trends, with Q3 2026 earnings (expected EPS $1.82) serving as the next key catalyst.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ROIV
100% Buy0% Sell
Avg holding period · 0 Days
VRT
50% Buy50% Sell
Avg holding period · 39 Days

Top news

Latest headlines on both assets

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →

About Vertiv Holdings Co

Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.

Read more on VRT →